How 'The Year of Ozempic' Transformed Obesity Treatment… and Much More

KQED's Forum

KQED

Politics, News, News Commentary

4.6 • 656 Ratings

🗓️ 4 January 2024

⏱️ 56 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

In a recent piece for the New Yorker called “The Year of Ozempic,” journalist and physician Dhruv Khullar writes that “we may look back on new weight-loss drugs as some of the greatest advances in the annals of chronic disease.” But the drugs don’t work for everyone, and there are ongoing questions about side effects, costs and availability. We’ll talk with Khullar about his piece and check in with UCSF weight loss doctor Diana Thiara about what we’ve learned about drugs like Ozempic and Wegovy over the past year. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	Support for Kikiwedi Podcasts comes from Rancho LaPuerta, boated the number one wellness resort and spa by readers of travel and leisure magazine. In August, three or four people sharing a cassida enjoy special vacation packages. Rancho LaPuerta.com
0:15.6	Support for Forum comes from Broadway SF, presenting Parade, the musical revival based on a true story.
0:23.0	From three-time Tony-winning composer Jason Robert Brown comes the story of Leo and Lucille Frank,
0:29.6	a newlywed Jewish couple struggling to make a life in Georgia. When Leo is accused of an
0:35.3	unspeakable crime, it propels them into an unimaginable test of faith, humanity, justice, and devotion.
0:43.3	The riveting and gloriously hopeful parade plays the Orpheum Theater for three weeks only, May 20th through June 8th.
0:51.7	Tickets on sale now at Broadwaysf.com.
0:56.5	From KQED Public Radio in San Francisco, I'm Leslie McClurg in Fermina Kim.
1:19.6	When I look around this room, I can't help but wonder, is OZMPIC right for me?
1:24.9	That's Jimmy Kimmel speaking to a crowd of very attractive actors at the Academy Awards
1:29.3	last spring.
1:30.3	His opening joke for the night made the audience roar.
1:33.3	It was also a key indication that the newest obesity drugs had gone mainstream.
1:37.3	Since then, the hype and hope around the drugs has only increased.
1:41.3	So what have we learned in the past year about their effectiveness,
1:44.6	side effects, and cost? Coming up on Forum, we'll get the latest on the weight loss revolution,
1:49.8	and we want to hear your experience. Email us now at Forum at KQED.org. That's next after this
1:55.9	news. This is Forum. I'm Leslie McClurg in today from Mina Kim. A few weeks ago, Oprah Winfrey told People magazine that she was taking one of the new class of weight loss drugs. That inspired a lot of people to follow her example.
2:11.9	Pharmacies are often sold out of Ozmpic and Weigoi. But even before Oprah's seal of approval, the hype, hope, and debate
2:19.1	around this new class of obesity drugs was already off the charts, driven in large part by
2:23.8	social media. In a recent piece in The New Yorker, journalist and physician Drew Kular writes
2:29.2	that the new drugs may be one of the greatest advances for chronic disease. He joins us now to talk about his piece
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from KQED, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of KQED and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.